Picture of GoodRx Holdings logo

GDRX — GoodRx Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousMid CapSuper Stock

GoodRx Holdings Inc reports results for the quarter ended in December - Earnings Summary

* GoodRx Holdings Inc  GDRX.OQ  reported quarterly adjusted
earnings of 8 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of 7 cents.  The mean expectation of
seventeen analysts for the quarter was for earnings of 7 cents
per share. Wall Street expected results to range from 1 cents
to 10 cents per share.
    * Revenue rose 6.8% to $196.64 million from a year ago;
analysts
expected $195.83 million. 
    * GoodRx Holdings Inc's reported EPS for the quarter was a
loss
of 6 cents​.
    * The company reported a quarterly loss of $25.87 million.
    * GoodRx Holdings Inc shares had fallen by 3.4% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 15.2%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 12
"hold" and 1 "sell" or "strong sell." 
    * Wall Street's median 12-month price target for GoodRx
Holdings
Inc is $7.00 

This summary was machine generated from LSEG data February 29 at
02:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      0.07           0.08           Beat
 Sep. 30 2023      0.06           0.06           Met
 Jun. 30 2023      0.06           0.07           Beat
 Mar. 31 2023      0.06           0.07           Beat

Recent news on GoodRx Holdings

See all news